Improvement of Sarcopenia in Patients Following Two Different Diets

CHU Brugmann University Hospital

Status: Withdrawn

Conditions: Sarcopenia

Treatments: Dietary Supplement: Oral dietary supplements

Study type: Interventional

Funder types: Other

Identifiers

NCT03405727

CHUB-diet

Details and patient eligibility

About

Sarcopenia is defined as a decrease in muscular strength and muscle mass, accompanied by a decrease in physical performance. Seniors might develop sarcopenia because of a decreased physical activity and a decreased protein intake. Many patients also develop sarcopenia after a long stay in an intensive care unit.

Protein intake is very important when treating sarcopenia. However, meeting the protein requirements at home proves difficult. Oral dietary supplements, given in addition to the other known recommendations, might provide a solution.

This study will assess the efficacy of the oral dietary supplements for the treatment of sarcopenia.

Sex: All

Ages: 65+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients hospitalized within the CHU Brugmann, Brussels
• Patients diagnosed with sarcopenia (by means of a dynamometer)
• Patients having stayed in an intensive care unit for longer than 5 weeks

Exclusion criteria

• Oncology patients
• Anorexic patients
• Patients having a life expectancy of less than 6 months
• Demented patients
• BPCO patients
• Patients with neuropathies

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

0 participants in 2 patient groups

Standard treatment

No Intervention group

Oral dietary supplements

Experimental group

Treatment:

Dietary Supplement: Oral dietary supplements